Home Effect of ozone gas on viral kinetics and liver histopathology in hepatitis C patients
Article
Licensed
Unlicensed Requires Authentication

Effect of ozone gas on viral kinetics and liver histopathology in hepatitis C patients

  • Ahmed Sadek , Ahmed M. Abd El Hady , Hammam Olfat , Afaf A. Abd El Hady , Wafaa Wafy , Moushira Zaki ORCID logo EMAIL logo and Eman R. Youness
Published/Copyright: January 10, 2024

Abstract

Objectives

We examine how well ozone/oxygen gas therapy treats chronic hepatitis C patients with varying degrees of liver fibrosis. Also to study the effect of giving multiple anti-oxidants with the ozone/oxygen gas mixture, to see if this addition would have any additive or synergistic effect.

Methods

Two hundred and twenty three patients with chronic hepatitis C. Liver biopsies were carried out at after 12 weeks of administering an ozone/oxygen gas mixture.

Results

The mean stage of fibrosis decreased from 1.98 to 1.41 and the mean grade of inflammation decreased from 10.08 to 7.94, both with a p value less than 0.001. After 12 weeks of treatment, mean PCR values increased. No single significant complication was recorded in a total of >9,000 settings of ozone therapy.

Conclusions

Ozone oxygen gas mixture is safe and effective in treatment of hepatic fibrosis due to chronic viral hepatitis C.


Corresponding author: Moushira Zaki, Department of Biological Anthropology, Medical Researches and Clinical Studies Institute, National Research Centre, Cairo, Egypt, E-mail:

Funding source: no funding

Acknowledgments

We thank all the participants.

  1. Research ethics: Approval of the ethics committee at the Theodor Bilharz Research Institute was taken prior to the study (registration number FWA 00010609).

  2. Informed consent: Written Consents was obtained from each participant in the current study.

  3. Author contributions: SA conceived the study, AAM Collected and Perform Experiment, HO did histopathological studies and supervised the study, AAA did PCR, EH reviewed the manuscript. MZ wrote, reviewed and proof read the final manuscript. ERY did the biochemical analysis, ERY, WW and SMA prepared and revised the manuscript.

  4. Competing interests: The authors state not conflict of interest.

  5. Research funding: None declared.

  6. Data availability: The data and materials used in this study are available upon request from the authors.

References

1. Jamison, DT, Summers, LH, Alleyne, G, Arrow, KJ, Berkley, S, Binagwaho, A, et al.. Global health 2035: a world converging within a generation. Lancet 2013;382:1898–955.10.1016/S0140-6736(13)62105-4Search in Google Scholar PubMed

2. Organization WH. Global health estimates. Geneva: World Heal. Organ.; 2012.Search in Google Scholar

3. Dolnikov, S, Adam, R, Cherqui, D, Allard, MA. Liver transplantation in elderly patients: what do we know at the beginning of 2020? Surg Today 2020;50:533–9.10.1007/s00595-020-01996-7Search in Google Scholar PubMed PubMed Central

4. Kim, AY, Chung, RT. Coinfection with HIV-1 and HCV – a one-two punch. Gastroenterology 2009;137:795–814.10.1053/j.gastro.2009.06.040Search in Google Scholar PubMed PubMed Central

5. Jani, P, Patel, G, Yadav, P, Sant, L, Jain, H. Ozone therapy: the alternative medicine of future. Indian J Phys Med Rehabil 2012;2:196–203.Search in Google Scholar

6. Janhom, N, Whangchai, K. Ozone fumigation promotes antioxidant activities to retard chlorophyll degradation and cell death in ‘Jinda’ chili during storage. Postharvest Biol Technol 2023;202:112375.10.1016/j.postharvbio.2023.112375Search in Google Scholar

7. Barnes, PJ, Karin, M. Nuclear factor-κB – a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066–71.10.1056/NEJM199704103361506Search in Google Scholar PubMed

8. Serra, MEG, Baeza-Noci, J, Abdala, CVM, Luvisotto, MM, Bertol, CD, Anzolin, AP. Clinical effectiveness of medical ozone therapy in COVID-19: the evidence and gaps map. Med Gas Res 2023;13:172.10.4103/2045-9912.372819Search in Google Scholar PubMed PubMed Central

9. Halfon, P, Khiri, H, Gerolami, V, Bourliere, M, Feryn, JM, Reynier, P, et al.. Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA. J Hepatol 1996;25:307–11.10.1016/S0168-8278(96)80116-4Search in Google Scholar PubMed

10. Germer, JJ, Harmsen, WS, Mandrekar, JN, Mitchell, PS, Yao, JDC. Evaluation of the COBAS TaqMan HCV test with automated sample processing using the MagNA pure LC instrument. J Clin Microbiol 2005;43:293–8.10.1128/JCM.43.1.293-298.2005Search in Google Scholar PubMed PubMed Central

11. Ishak, K, Baptista, A, Bianchi, L, Callea, F, De Groote, J, Gudat, F, et al.. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696–9.10.1016/0168-8278(95)80226-6Search in Google Scholar PubMed

12. Asrani, SK, Devarbhavi, H, Eaton, J, Kamath, PS. Burden of liver diseases in the world. J Hepatol 2019;70:151–71.10.1016/j.jhep.2018.09.014Search in Google Scholar PubMed

13. Bach, N, Thung, SN, Schaffner, F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992;15:572–7.10.1002/hep.1840150403Search in Google Scholar PubMed

14. Bility, MT, Cheng, L, Zhang, Z, Luan, Y, Li, F, Chi, L, et al.. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog 2014;10:e1004032.10.1371/journal.ppat.1004032Search in Google Scholar PubMed PubMed Central

15. Xing, Y, Zhong, W, Peng, D, Han, Z, Zeng, H, Wang, Y, et al.. Chinese herbal formula ruangan granule enhances the efficacy of entecavir to reverse advanced liver fibrosis/early cirrhosis in patients with chronic HBV infection: a multicenter, randomized clinical trial. Pharmacol Res 2023;190:106737.10.1016/j.phrs.2023.106737Search in Google Scholar PubMed

16. Chen, Y, Li, J, Zeng, M, Lu, L, Qu, D, Mao, Y, et al.. The inhibitory effect of oxymatrine on hepatitis C virus in vitro. Chinese J Hepatol 2001;9:12–4.Search in Google Scholar

17. Yang, W, Zeng, M, Fan, Z, Mao, Y, Song, Y, Jia, Y, et al.. Prophylactic and therapeutic effect of oxymatrine on D-galactosamine-induced rat liver fibrosis. Chinese J Hepatol 2002;10:193–6.Search in Google Scholar

18. Fallowfield, JA, Iredale, JP. Reversal of liver fibrosis and cirrhosis – an emerging reality. Scott Med J 2004;49:3–6.10.1177/003693300404900101Search in Google Scholar PubMed

19. Kim, K-Y, Choi, I, Kim, S-S. Progression of hepatic stellate cell activation is associated with the level of oxidative stress rather than cytokines during CCl4-induced fibrogenesis. Mol Cells. 2000;10:289–300.10.1016/S1016-8478(23)17477-2Search in Google Scholar

20. Coutinho, EM, Barros, AF, Barbosa, AJr, Oliveira, SA, Silva, LM, Araújo, RE, et al.. Host nutritional status as a contributory factor to the remodeling of schistosomal hepatic fibrosis. Mem Inst Oswaldo Cruz 2003;98:919–25.10.1590/S0074-02762003000700011Search in Google Scholar PubMed

21. Lu, LG, Zeng, MD, Mao, YM, Wan, MB, Li, CZ, Chen, CW, et al.. Medicinal Herbs for HCV (oxymatrin). World J Gastroenterol 2003;9:2480–3.10.3748/wjg.v9.i11.2480Search in Google Scholar PubMed PubMed Central

22. Wu, J, Zern, MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 2000;35:665–72.10.1007/s005350070045Search in Google Scholar PubMed

23. Ferret, P-J, Hammoud, R, Tulliez, M, Tran, A, Trébéden, H, Jaffray, P, et al.. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. Hepatology 2001;33:1173–80.10.1053/jhep.2001.24267Search in Google Scholar PubMed

24. Bocci, V. Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediators Inflamm 2004;13:3–11.10.1080/0962935062000197083Search in Google Scholar PubMed PubMed Central

25. Schwabe, RF, Schnabl, B, Kweon, YO, Brenner, DA. CD40 activates NF-κB and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells. J Immunol 2001;166:6812–9.10.4049/jimmunol.166.11.6812Search in Google Scholar PubMed

26. Dooley, S, Hamzavi, J, Breitkopf, K, Wiercinska, E, Said, HM, Lorenzen, J, et al.. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 2003;125:178–91.10.1016/S0016-5085(03)00666-8Search in Google Scholar

27. Marra, F, Efsen, E, Romanelli, RG, Caligiuri, A, Pastacaldi, S, Batignani, G, et al.. Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000;119:466–78.10.1053/gast.2000.9365Search in Google Scholar PubMed

28. Boya, P, Larrea, E, Sola, I, Majano, P-L, JIMenez, C, Civeira, M-P, et al.. Nuclear factor-κb in the liver of patients with chronic hepatitis c: decreased rela expression is associated with enhanced fibrosis progression. Hepatology 2001;34:1041–8.10.1053/jhep.2001.29002Search in Google Scholar PubMed

29. Poynard, T, McHutchison, J, Manns, M, Trepo, C, Lindsay, K, Goodman, Z, et al.. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002;122:1303–13.10.1053/gast.2002.33023Search in Google Scholar PubMed

30. Mao, Y-M, Zeng, M-D, Lu, L-G, Wan, M-B, Li, C-Z, Chen, C-W, et al.. Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study. World J Gastroenterol 2004;10:3269.10.3748/wjg.v10.i22.3269Search in Google Scholar PubMed PubMed Central

31. Sookoian, S, Fernández, MA, Castaño, G. Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study. World J Gastroenterol 2005;11:7560.10.3748/wjg.v11.i48.7560Search in Google Scholar PubMed PubMed Central

Received: 2023-09-05
Accepted: 2023-10-30
Published Online: 2024-01-10

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Markhamia lutea leaves aqueous and ethanolic extract with curative anti-inflammatory activity attenuates paclitaxel toxicity in rat’s intestine
  4. Does hydrotherapy influence plasma glucose levels in type 2 diabetes? – A scoping review
  5. Comparative effectiveness is the common denominator in health services research: experimental effects are promising, real-world effects are compelling
  6. Research Articles
  7. Hydroethanolic extract of Piliostigma thonningii leaves extenuates the severity of diarrhoea in female Wistar rats
  8. Pharmacokinetic assessment of rifampicin and des-acetyl rifampicin in carbon tetrachloride induced liver injury model in Wistar rats
  9. Antipyretic activity of the hydro-alcoholic extract of Artemisia absinthium L. as a standalone and as an adjuvant with barley water against yeast-induced pyrexia in albino Wistar rats
  10. Selenium prevented renal tissue damage in lipopolysaccharide-treated rats
  11. Preliminary data on cytotoxicity and functional group assessment of a herb–mineral combination against colorectal carcinoma cell line
  12. Oral intake of collagen hydrolysate from mackerel scad (Decapterus macarellus) attenuates skin photoaging by suppressing the UVB-induced expression of MMP-1 and IL-6
  13. Pentaclethra macrophylla leaves reduce blood glucose level, improve sexual behavior and modulate critical enzymes associated with diabetes-erectile dysfunction morbidity in rats
  14. Anti-melanoma and antioxidant properties of the methanol extract from the leaves of Phragmenthera capitata (Spreng.) Balle and Globimetula braunii (Engl.) Van Tiegh
  15. The assessment of the mechanism of action of lauric acid in the context of oral cancer through integrative approach combining network pharmacology and molecular docking technology
  16. Therapeutic potential of flavonoids in ovalbumin induced asthma in mice model
  17. The effects of pioglitazone and rosiglitazone on liver function in hypothyroid rats
  18. Effect of ozone gas on viral kinetics and liver histopathology in hepatitis C patients
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jcim-2023-0239/pdf
Scroll to top button